Research Highlight

BC Cancer Consortium leadership and members share updates with the Network

On Thursday, June 27th, leadership and researchers from the BC Cancer Consortium presented their work to Network members as part of the MOHCCN seminar series. 

This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. 

This event was co-chaired by Rosilene Kraft, PhD, PEng, MOHCCN Patient Working Group member, and Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.

Watch the full video

 

Speakers

BC2C CONSORTIUM ACTIVITIES UPDATE

Dr. Daniel Renouf - Medical Oncologist and Executive Medical Director, BC Cancer - Vancouver; Associate Professor, Faculty of Medicine, UBC; MOHCCN consortium lead (BC2C)

RESEARCH PRESENTATIONS

Multimode whole genome approaches to plasma-based disease monitoring in triple-negative breast cancer

Dr. Samuel Aparicio - Professor, Department of Pathology and Laboratory Medicine, UBC; Head, Department of Breast and Molecular Oncology, BC Cancer Research Institute; MOHCCN cohort lead

Synovial sarcoma chromatin dynamics reveal a continuum in SS18::SSX reprogramming

Kiera Lee - MD/PhD Candidate, Department of Microbiology and Immunology, Michael Smith Laboratories, UBC

 

Related Team Members

  • Regional Consortia

    BC Cancer Consortium

    • British Columbia
    The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...
    Read more
    • BC Cancer Logo
    BCCA_CRC Vancouver